UrapidilHCl , 99% , 64887-14-5
                            Synonym(s):
6-[[3-[4-(o-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyluracil hydrochloride
                            
                        
                CAS NO.:64887-14-5
Empirical Formula: C20H30ClN5O3
Molecular Weight: 423.94
MDL number: MFCD00078601
EINECS: 636-348-0
| Pack Size | Price | Stock | Quantity | 
| 5mg | RMB145.60 | In Stock | 
                                                 | 
                                        
| others | Enquire | 
PRODUCT Properties
| Melting point: | 156-1580C | 
                                    
| storage temp. | Keep in dark place,Inert atmosphere,Room temperature | 
                                    
| solubility | H2O: soluble | 
                                    
| form | solid | 
                                    
| color | white | 
                                    
| Water Solubility | Soluble to 50 mM in water | 
                                    
| InChI | InChI=1S/C20H29N5O3.ClH/c1-22-18(15-19(26)23(2)20(22)27)21-9-6-10-24-11-13-25(14-12-24)16-7-4-5-8-17(16)28-3;/h4-5,7-8,15,21H,6,9-14H2,1-3H3;1H | 
                                    
| InChIKey | KTMLZVUAXJERAT-UHFFFAOYSA-N | 
                                    
| SMILES | O(C1C=CC=CC=1N1CCN(CCCNC2=CC(=O)N(C)C(=O)N2C)CC1)C.Cl | 
                                    
Description and Uses
Urapidil is an antagonist of α1-adrenergic receptors (α1-ARs) and a partial agonist of the serotonin (5-HT) receptor subtype 5-HT1A. It selectively binds to α1- over α2-ARs (IC50s = 0.74 and 42 μM, respectively) and to 5-HT1A over 5-HT1B and 5-HT2 receptors (IC50s = 0.4, 20.4, and >10 μM, respectively) in rat cortex. Urapidil inhibits cAMP accumulation induced by forskolin in calf hippocampus as a functional model for 5-HT1A receptors (EC50 = 390 nM). It is also a β1-AR antagonist that inhibits the positive chronotropic response induced by isoproterenol in isolated rat atria (pA2 = 6.05). Urapidil (1 μmol/kg, i.v.) lowers mean arterial pressure (MAP) in anesthetized cats, an effect that is reduced by central administration of the 5-HT1A receptor antagonist spiroxatrine.
Antihypertensive;Serotonergic receptor agonist
Safety
| Symbol(GHS) | ![]() GHS07  | 
                                    
| Signal word | Warning | 
| Hazard statements | H302 | 
| Precautionary statements | P264-P270-P301+P312-P501 | 
| Hazard Codes | Xn | 
| Risk Statements | 22-36/37/38 | 
| Safety Statements | 26-36 | 
| WGK Germany | 3 | 
| RTECS | YQ9862000 | 




